Financial Trading Blog
UK Tobacco Giants' Earnings Disappoint, But One Soared! Here's Why.
UK Tobacco companies face declining demand due to health concerns, smoking bans and high taxes, which prompt many consumers to quit or switch to vaping products.
BAT Takes Huge Impairment Loss on US Brands, But Soared
British American Tobacco (BAT) reported a huge loss for 2023 due to an impairment charge related to its US business. They decided to write down the value of brands like Camel and Pall Mall, in addition to an impairment of the goodwill from their 2017 acquisition of Reynolds American. Amounting a total of £27.6 billion, the company said it was hit hard by "macro-economic pressures and proliferation of illicit single-use vapour products". Revenues also declined slightly by 1.3% to £27.2 billion.
Given the lack of income streams from new segments to replace cigarette sales, BAT's earnings outlook remains challenging. The company forecasts that global tobacco volumes will fall around 3% this year due to poor performance in the US and Indonesia. They said they will shift focus to smokeless products, aiming to get 50% of their revenue by 2035.
Despite the pessimistic news, investors were bullish that BAT may sell part of its nearly 30% stake in Indian peer ITC. The CEO said they are working to get regulatory approval to sell some of its ITC shares, which could increase funds for shareholder returns. BAT shares were up around 8% as investors welcomed the move towards share buybacks.
Analysts said that in addition to the potential ITC stake sale, the market was relieved that BAT's dividend extended its 25-year dividend growth after some concerns it could be cut. The yield is around 10% at the current price. In contrast, BAT's rival Philip Morris International missed analyst expectations for its quarterly profit and full-year forecasts, weighing on its shares.
Phillip Morris Takes Hit From EPS Miss
Phillip Morris' share price declined after announcing its latest financial results. While total revenue increased 11% to $9.05 billion, beating analyst forecasts, earnings per share fell year-on-year to $1.36 but was above expectations of $1.45. Price rises and currency fluctuations drove revenue growth, as organic sales volume rose by a more modest 8.3%.
Analysts noted disappointing growth across cigarettes and heated tobacco unit (HTU) shipments, which fell 0.5%. HTU volumes increased by 6.1%, but this was considered underwhelming compared to the 11.6% growth reported earlier by BAT. Heated tobacco unit shipments of 33.97 billion also failed to meet the consensus forecast of 35.32 billion.
EPS guidance of $6.30-6.44 for the full year further dampened investor sentiment for the full year, below the $6.60 expected. However, the company's CEO remained optimistic, doubling down on the company's pivot to reduced-risk products and projecting sales volume growth of 14-16% over the coming months. This suggests Phillip Morris may recover lost ground in the near future.
BAT Record Low Might Be In
On 6 December, BAT's share price reached a record low after announcing the loss of business in the US. With this news now reflected in the share price and an increase following the sale of ITC shares, the share price will need to surpass 2570 and 2750 to increase further potentially. 2750 may act as the upper "neckline" limit of a potential "head and shoulders" pattern, with a major correction expected at this level. Until this point, the share price trend remains positive as it trades above the upper limit of its rising channel. However, closing below 2360, the initial gap open could change the dynamics, exposing the share price to dropping as low as 2250 or even a new record low.
Key Takeaways
BAT reported a huge loss due to an impairment charge related to its struggling US business. Revenues also declined slightly by 1.3% to £27.2 billion, with BAT's outlook difficult as global tobacco volumes are forecasted to fall around 3% this year. However, investors were optimistic the company may sell part of its stake in Indian peer ITC. BAT shares rallied around 8% on the news of a potential stake sale and maintained a dividend. In contrast, Phillip Morris's share price declined after missing analysts' expectations. While revenue increased by 11%, EPS fell, and growth in HTUt shipments was disappointing.
It's easy to open an account
- Fill in our simple online application form
- Fund your account
- Start trading the global markets instantly!
SEARCH FOR AN ARTICLE:
Enter a keyword and search for all relevant articlesMARKET ANALYSIS
RECENT POSTS
DISCLAIMER
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.
Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.
No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.
The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.